Background/Aims: According to previous observations, enhanced store-operated Ca 2+ -entry (SOCE) accomplished by the pore forming ion channel unit Orai1 and its regulator STIM1 contribute to therapy resistance of ovary carcinoma cells. Ca 2+ signaling is further shaped by Ca 2+ extrusion through K + -independent (NCX) and/or K + -dependent (NCKX) Na + /Ca 2+ -exchangers. The present study thus explored whether therapy resistance is further paralleled by altered expression and/or function of Na + /Ca 2+ -exchangers. Methods: In therapy resistant (A2780cis) and therapy sensitive (A2780sens) 
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Introduction

Alterations of cytosolic Ca
2+ activity contribute to the regulation of diverse cellular mechanisms, such as excitation, exocytosis, migration, cell proliferation and cell death [1] [2] [3] [4] [5] release from intracellular stores with subsequent triggering of store operated Ca 2+ entry (SOCE) accomplished by Orai [6] [7] [8] [9] [10] and STIM [11] [12] [13] [14] [15] isoforms. Orai1 and STIM1 are expressed in and contribute to the survival of several tumor cells [16] [17] [18] [19] [20] including therapy resistant ovary carcinoma cells [21] .
Cytosolic exchanger activity determined and the impact of NCX inhibition on cisplatin induced cell death analyzed.
Materials and Methods
Ethics Statement
Investigation has been conducted in accordance with the ethical standards and according to the Declaration of Helsinki and according to national and international guidelines and has been approved by the authors' institutional review board. Specificity of PCR products was confirmed by analysis of a melting curve. Real-time PCR amplifications were performed on a CFX96 Real-Time System (Bio-Rad) and all experiments were done in duplicate. The house-keeping gene GAPDH (Glycerinaldehyd-3-phosphat-Dehydrogenase) was amplified to standardize the amount of sample RNA. Relative quantification of gene expression was achieved using the ΔCT method as described earlier [35, 36] .
Ca
2+ measurements Fura-2 fluorescence was utilized to determine intracellular Ca 2+ activity [37] . Cells were loaded with Fura-2/AM (2 µM, Invitrogen, Goettingen, Germany) for 20-60 min at 37°C. Cells were excited alternatively at 340 nm and 380 nm through an objective (Fluor 40×/1.30 oil) built in a fluorescence microscope (Axiovert 100, Zeiss, Oberkochen, Germany). Emitted fluorescence intensity was recorded at 505 nm. Data were acquired using specialized computer software (Metafluor, Universal Imaging, Downingtown, USA 
Patch clamp
Patch clamp experiments were performed at room temperature in voltage-clamp, fast-whole-cell mode according to Hamill et al. [38] . The cells were continuously superfused through a flow system inserted into the dish. Borosilicate glass pipettes (2-5 MΏ tip resistance; Harvard Apparatus, Kent, UK) manufactured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) were used in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, N.Y., USA). The currents were recorded with an acquisition frequency of 10 kHz and 3 kHz low-pass filtered. The offset potentials between both electrodes were zeroed before sealing. Whole-cell currents elicited by changing the bath solutions were measured during a continuous 40 second square wave voltage pulse to -80 mV. The applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. The outward currents, defined as flow of positive charge from the cytoplasmic to the extracellular membrane face, are positive currents and depicted as outward deflections of the original current traces. To measure Na 
Determination of apoptosis
To determine apoptosis, 10 5 cells/100 μl in complete RPMI were centrifuged at 1000 rpm for 5 minutes at 24 o C, added to 200 μl of PBS containing 50 μg/ml propidium iodide (Mabtag, Germany) as well as incubated at room temperature in the dark for 10 minutes. The cells were washed once at 1000 rpm for 5 minutes, resuspended in PBS and measured immediately with an excitation wavelength of 488 nm and an emission wavelength of 585 nm (FL-2) with flow cytometry [39] utilizing a FACS Calibur (BD, Heidelberg, Germany). 
Results
The present study addressed the putative role of Na + /Ca 2+ exchangers in therapy resistance of ovary carcinoma cells. We first quantified and compared the different transcript levels of the Na + /Ca 2+ exchanger isoforms in therapy sensitive A2780sens and therapy resistant A2780cis ovary carcinoma cells using quantitative real-time-PCR. To this end the respective transcript levels were quantified in therapy sensitive A2780sens and the therapy resistant A2780cis ovary carcinoma cells by using real time-PCR. As illustrated in Fig.1 , both cell lines express the NCX isoforms NCX1 and NCX3, but very little NCX2 (Fig.1A) . The transcript levels of NCX3, but not those of NCX1 were significantly higher in therapy resistant than in therapy sensitive ovary carcinoma cells (Fig. 1B) . As shown in Fig. 2 , ovary carcinoma cells further express several NCKX isoforms. The transcript levels of NCKX1 were similar in therapy resistant and in therapy sensitive ovary carcinoma cells. However, the transcript levels of NCKX4, NCKX5, and NCKX6 were significantly higher in therapy resistant as compared to therapy sensitive ovary carcinoma cells (Fig. 2B ). NCKX3 transcript levels were not detectable (data not shown).
In the next step, Fura-2 fluorescence was employed to explore whether the differences in NCX and NCKX transcript levels were paralleled by the respective differences in Na Pelzl -containing (2 mM) extracellular solution. Prior to Na + removal the Fura2-fluorescence ratio was similar in therapy sensitive (0.53 ± 0.01 a.u., n = 8) and therapy resistant (0.56 ± 0.01 a.u., n = 10) ovary carcinoma cells.
As illustrated in Fig. 3 , the removal of external Na + and addition of external Ca 2+ was followed by an increase of [Ca 2+ ] i , which was significantly more pronounced in therapy resistant than in therapy sensitive ovary carcinoma cells. Fig. 3 Fig. 4 , in the presence K + , the removal of external Na + and addition of external Ca 2+ was followed by an increase of [Ca 2+ ] i , which was significantly more pronounced in therapy resistant than in therapy sensitive ovary carcinoma cells. Fig. 4 -containing (2 mM) solution. The removal of external Na + and addition of Ca 2+ was followed by an outward current, which was significantly larger in therapy resistant than in therapy sensitive ovary carcinoma cells (Fig. 5) .
further illustrates
A further series of experiments addressed the impact of the Na + /Ca 2+ exchangers on the therapy resistance of ovary carcinoma cells. To this end, therapy resistant and therapy sensitive ovary carcinoma cells were treated with cisplatin (100 µM, 24 h) in the absence or presence of the Na + /Ca 2+ exchanger inhibitor KB-R7943 (10 µM). Cisplatin treatment significantly increased the percentage of propodium iodide containing ovary carcinoma cells, an effect significantly more pronounced in therapy sensitive than in therapy resistant ovary carcinoma cells (Fig. 6) . The additional treatment with KB-R7943 did not significantly affect cell death of therapy sensitive ovary carcinoma cells; but significantly increased the percentage of apoptotic therapy resistant ovary carcinoma cells (Fig. 6C) . 
Discussion
The present study revealed the expression of several Na + /Ca 2+ exchanger isoforms in ovary carcinoma cells. In both, therapy resistant and therapy sensitive ovary carcinoma cells, transcript levels were detected encoding the Na + /Ca 2+ exchangers NCX1, NCX3, NCKX1, NCKX2, NCKX4, NCKX5, and NCKX6. More importantly, the transcript levels of NCX3 and of NCKX4, NCKX5 and NCKX6 were more abundant in therapy resistant than in therapy sensitive ovary carcinoma cells. The increased abundance of mRNA encoding the respective Na + /Ca 2+ exchanger isoforms was paralleled by similar increases of Na + /Ca 2+ exchanger activities.
Previous observations disclosed increased expression of both, Orai1 and STIM1 in therapy resistant as compared to therapy sensitive ovary carcinoma cells [21] . The increased expression of Orai1 and STIM1 was paralleled by increased store operated Ca 2+ entry (SOCE) in therapy resistant ovary carcinoma cells. Pharmacological inhibition of Orai1 augmented cisplatin induced apoptosis of therapy resistant ovary carcinoma cells and virtually abrogated the differences in cisplatin sensitivity between therapy sensitive and therapy resistant ovary carcinoma cells [21] . The Orai isoforms Orai1, 2, or 3 [6] [7] [8] [9] and their regulators STIM 1 or 2 [49] which are decisive in the regulation of diverse cellular functions [23, [50] [51] [52] [53] , such as entrance into the S and the M phase of the cell cycle [54, 55] and support of tumor cell survival [56, 57] 
